NO308305B1 - FremgangsmÕte for rensing og isolering av et <beta>- anomeranriket nukleosid - Google Patents

FremgangsmÕte for rensing og isolering av et <beta>- anomeranriket nukleosid

Info

Publication number
NO308305B1
NO308305B1 NO972214A NO972214A NO308305B1 NO 308305 B1 NO308305 B1 NO 308305B1 NO 972214 A NO972214 A NO 972214A NO 972214 A NO972214 A NO 972214A NO 308305 B1 NO308305 B1 NO 308305B1
Authority
NO
Norway
Prior art keywords
beta
isolation
purification
procedure
anomer enriched
Prior art date
Application number
NO972214A
Other languages
English (en)
Norwegian (no)
Other versions
NO972214D0 (no
NO972214L (no
Inventor
Ta-Sen Chou
Laurie Michelle Poteet
Douglas Patton Kjell
Original Assignee
Lilly Co Eli
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=23335711&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=NO308305(B1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Lilly Co Eli filed Critical Lilly Co Eli
Publication of NO972214D0 publication Critical patent/NO972214D0/no
Publication of NO972214L publication Critical patent/NO972214L/no
Publication of NO308305B1 publication Critical patent/NO308305B1/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H19/00—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
    • C07H19/02—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
    • C07H19/04—Heterocyclic radicals containing only nitrogen atoms as ring hetero atom
    • C07H19/06—Pyrimidine radicals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H19/00—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
    • C07H19/02—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
    • C07H19/04—Heterocyclic radicals containing only nitrogen atoms as ring hetero atom
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00—Technologies relating to chemical industry
    • Y02P20/50—Improvements relating to the production of bulk chemicals
    • Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Biotechnology (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Saccharide Compounds (AREA)
  • Cephalosporin Compounds (AREA)
NO972214A 1994-11-17 1997-05-14 FremgangsmÕte for rensing og isolering av et <beta>- anomeranriket nukleosid NO308305B1 (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US08/340,972 US5606048A (en) 1992-06-22 1994-11-17 Stereoselective glycosylation process for preparing 2'-Deoxy-2', 2'-difluoronucleosides and 2'-deoxy-2'-fluoronucleosides
PCT/US1995/014086 WO1996016072A1 (en) 1994-11-17 1995-11-01 Process for purifying and isolating 2'-deoxy-2',2'-difluoronucleosides

Publications (3)

Publication Number Publication Date
NO972214D0 NO972214D0 (no) 1997-05-14
NO972214L NO972214L (no) 1997-05-14
NO308305B1 true NO308305B1 (no) 2000-08-28

Family

ID=23335711

Family Applications (1)

Application Number Title Priority Date Filing Date
NO972214A NO308305B1 (no) 1994-11-17 1997-05-14 FremgangsmÕte for rensing og isolering av et <beta>- anomeranriket nukleosid

Country Status (34)

Country Link
US (1) US5606048A (sh)
EP (1) EP0712860B1 (sh)
JP (1) JPH10509170A (sh)
KR (1) KR100424990B1 (sh)
CN (1) CN1044119C (sh)
AR (1) AR001045A1 (sh)
AT (1) ATE210142T1 (sh)
AU (1) AU702588B2 (sh)
BG (1) BG62737B1 (sh)
BR (1) BR9509904A (sh)
CA (1) CA2205350C (sh)
CO (1) CO4600741A1 (sh)
CZ (1) CZ292013B6 (sh)
DE (1) DE69524365T2 (sh)
DK (1) DK0712860T3 (sh)
ES (1) ES2164745T3 (sh)
HU (1) HU219019B (sh)
IL (1) IL115854A (sh)
MX (1) MX9703548A (sh)
MY (1) MY115183A (sh)
NO (1) NO308305B1 (sh)
NZ (1) NZ296712A (sh)
PE (1) PE50196A1 (sh)
PL (1) PL182052B1 (sh)
PT (1) PT712860E (sh)
RO (1) RO118296B1 (sh)
RU (1) RU2161622C2 (sh)
SI (1) SI0712860T1 (sh)
SK (1) SK283160B6 (sh)
TW (1) TW377356B (sh)
UA (1) UA53614C2 (sh)
WO (1) WO1996016072A1 (sh)
YU (1) YU49446B (sh)
ZA (1) ZA959321B (sh)

Families Citing this family (45)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6326507B1 (en) * 1998-06-19 2001-12-04 Trustees Of Dartmouth College Therapeutic compounds and methods of use
MY164523A (en) 2000-05-23 2017-12-29 Univ Degli Studi Cagliari Methods and compositions for treating hepatitis c virus
NZ547204A (en) * 2000-05-26 2008-01-31 Idenix Cayman Ltd Methods and compositions for treating flaviviruses and pestiviruses
US7435755B2 (en) * 2000-11-28 2008-10-14 The Trustees Of Dartmouth College CDDO-compounds and combination therapies thereof
EP1465615B1 (en) * 2002-01-15 2012-08-01 Trustees of Dartmouth College Tricyclic-bis-enone derivatives and methods of use thereof
NZ537662A (en) * 2002-06-28 2007-10-26 Idenix Cayman Ltd 2'-C-methyl-3'-O-L-valine ester ribofuranosyl cytidine for treatment of flaviviridae infections
JP2005533824A (ja) * 2002-06-28 2005-11-10 イデニクス（ケイマン）リミテツド フラビウイルス科感染の治療のための２’−ｃ−メチル−３’−ｏ−ｌ−バリンエステルリボフラノシルシチジン
US7608600B2 (en) 2002-06-28 2009-10-27 Idenix Pharmaceuticals, Inc. Modified 2′ and 3′-nucleoside prodrugs for treating Flaviviridae infections
EP1567169A4 (en) * 2002-11-04 2009-10-21 Xenoport Inc GEMCITABINE PROMOTERS, THEIR PHARMACEUTICAL COMPOSITIONS AND USES THEREOF
WO2004046331A2 (en) * 2002-11-15 2004-06-03 Idenix (Cayman) Limited 2’-branched nucleosides and flaviviridae mutation
WO2004052899A2 (en) * 2002-12-12 2004-06-24 Idenix (Cayman) Limited Process for the production of 2'-branched nucleosides
WO2006000922A2 (en) * 2004-06-23 2006-01-05 Idenix (Cayman) Limited 5-aza-7-deazapurine derivatives for treating infections with flaviviridae
US7214791B2 (en) * 2004-07-01 2007-05-08 Shenzhen Hande Technology Co., Ltd. Method for preparation of 2′-deoxy-2′, 2′-difluoro-β-cytidine or pharmaceutically acceptable salts thereof by using 1,6-anhydro-β-d-glucose as raw material
JP2007522151A (ja) * 2004-12-08 2007-08-09 シコール インコーポレイティド ジフルオロヌクレオシド及びその調製方法
WO2006070985A1 (en) * 2004-12-30 2006-07-06 Hanmi Pharm. Co., Ltd. METHOD FOR THE PREPARATION OF 2&num;-DEOXY-2&num;,2&num;-DIFLUOROCYTIDINE
BRPI0514718A (pt) * 2004-12-30 2008-07-01 Hanmi Pharm Ind Co Ltd método para a preparação de 2'-desoxi-2', 2'-diflúor-citidina
JP2008531680A (ja) * 2005-03-04 2008-08-14 ダブール・ファーマ・リミテッド βアノマーが富化された２１−デオキシ−２１，２１−ジフルオロ−Ｄ−リボフラノシルヌクレオシドの調製のための中間体と方法
JP4516863B2 (ja) * 2005-03-11 2010-08-04 株式会社ケンウッド 音声合成装置、音声合成方法及びプログラム
US7572898B2 (en) * 2005-06-03 2009-08-11 Scinopharm Taiwan, Ltd. Process of making an alpha-anomer enriched 2-deoxy-2,2-difluoro-D-ribofuranosyl sulfonate and use thereof for making a beta nucleoside
AU2011202539B2 (en) * 2005-06-03 2012-07-05 Scinopharm Taiwan, Ltd. Process of making an alpha-anomer enriched 2-deoxy-2,2-difluoro-d-ribofuranosyl sulfonate and use thereof for making a beta nucleoside
EP1940859A1 (en) * 2005-10-28 2008-07-09 Arch Pharmalabs Limited An improved process for preparation of gemcitabine hydrochloride
US7781576B2 (en) * 2005-12-23 2010-08-24 Idenix Pharmaceuticals, Inc. Process for preparing a synthetic intermediate for preparation of branched nucleosides
JP2009531284A (ja) * 2006-02-06 2009-09-03 ドクター レディズ ラボラトリーズ リミテッド ゲムシタビンの調製
US8921340B2 (en) 2006-11-17 2014-12-30 Trustees Of Dartmouth College Methods for using synthetic triterpenoids in the treatment of bone or cartilage diseases or conditions
CA2670099A1 (en) * 2006-11-17 2008-05-29 Trustees Of Dartmouth College Synthesis and biological activities of new tricyclic-bis-enones (tbes)
WO2008064132A2 (en) * 2006-11-17 2008-05-29 Trustees Of Dartmouth College Synthetic triterpenoids and tricyclic-bis-enones for use in stimulating bone and cartilage growth
JP5349342B2 (ja) * 2007-03-23 2013-11-20 ドンウ シンテック カンパニー リミテッド ２’−デオキシ−２’，２’−ジフルオロシチジンの製造方法
CN100475832C (zh) 2007-05-31 2009-04-08 南京卡文迪许生物工程技术有限公司 一种新颖的高立体选择性合成吉西他滨工艺及中间体
WO2009023845A2 (en) * 2007-08-15 2009-02-19 The Board Of Regents Of The University Of Texas System Combination therapy with synthetic triterpenoids and gemcitabine
EP2050757A1 (en) 2007-10-10 2009-04-22 Cilag AG Method of producing 2' -deoxy-5-azacytidine (Decitabine)
JO2778B1 (en) 2007-10-16 2014-03-15 ايساي انك Certain vehicles, installations and methods
EA022166B1 (ru) * 2008-01-11 2015-11-30 Ритэ Фамэсутиклс, Инк. Синтетические тритерпеноиды и их применение в лечении заболеваний
CN102083442B (zh) 2008-04-18 2014-08-13 里亚塔医药公司 抗氧化剂炎症调节剂：在c-17具有氨基和其它修饰的齐墩果酸衍生物
CN102164941B (zh) 2008-04-18 2015-05-27 里亚塔医药公司 抗氧化剂炎症调节剂:具有饱和c环的齐墩果酸衍生物
US7943778B2 (en) 2008-04-18 2011-05-17 Reata Pharmaceuticals, Inc. Antioxidant inflammation modulators: C-17 homologated oleanolic acid derivatives
TW201004627A (en) 2008-04-18 2010-02-01 Reata Pharmaceuticals Inc Antioxidant inflammation modulators: novel derivatives of oleanolic acid
CA2721665C (en) 2008-04-18 2017-01-24 Reata Pharmaceuticals, Inc. Compounds including an anti-inflammatory pharmacore and methods of use
US8314137B2 (en) * 2008-07-22 2012-11-20 Trustess Of Dartmouth College Monocyclic cyanoenones and methods of use thereof
US8609631B2 (en) 2009-04-06 2013-12-17 Eisai Inc. Compositions and methods for treating cancer
US8324180B2 (en) * 2009-04-06 2012-12-04 Eisai Inc. Compositions and methods for treating cancer
ES2628609T3 (es) * 2009-04-06 2017-08-03 Otsuka Pharmaceutical Co., Ltd. Combinación de fármacos antineoplásicos a base de citidina con inhibidor de citidina deaminasa y uso del mismo en el tratamiento de cáncer
CA2757744C (en) * 2009-04-06 2018-02-13 Eisai Inc. Combination of decitabine with cytidine deaminase inhibitor and use thereof in the treatment of cancer
RS57449B1 (sr) 2012-04-04 2018-09-28 Halozyme Inc Kombinovana terapija sa hijaluronidazom i taksanom koji ciljno deluje na tumor
US8921419B2 (en) 2012-05-08 2014-12-30 Trustees Of Dartmouth College Triterpenoids and compositions containing the same
US20190351031A1 (en) 2018-05-16 2019-11-21 Halozyme, Inc. Methods of selecting subjects for combination cancer therapy with a polymer-conjugated soluble ph20

Family Cites Families (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3282921A (en) * 1964-06-04 1966-11-01 Syntex Corp Halo-deoxynucleosides and processes for the preparation thereof
US3721664A (en) * 1970-01-27 1973-03-20 Hoffmann La Roche Preparation of 5-cytosine nucleosides
DE2628202A1 (de) * 1976-06-23 1977-12-29 Max Planck Gesellschaft Verfahren zur herstellung von 2'-substituierten-d-ribofuranosylpurinderivaten
DE2721466A1 (de) * 1977-05-12 1978-11-16 Robugen Gmbh Verfahren zur herstellung von 2'-desoxyribofuranosylnucleosiden
US4211773A (en) * 1978-10-02 1980-07-08 Sloan Kettering Institute For Cancer Research 5-Substituted 1-(2'-Deoxy-2'-substituted-β-D-arabinofuranosyl)pyrimidine nucleosides
FR2531962B1 (fr) * 1982-08-17 1986-11-14 Sandoz Sa Nouveaux derives de la desoxyuridine, leur preparation et leur utilisation comme medicaments
US4526988A (en) * 1983-03-10 1985-07-02 Eli Lilly And Company Difluoro antivirals and intermediate therefor
US4625020A (en) * 1983-11-18 1986-11-25 Bristol-Myers Company Nucleoside process
CA1295998C (en) * 1985-07-29 1992-02-18 Sai P. Sunkara Nucleosides and their use as antineoplastic agents
US4751221A (en) * 1985-10-18 1988-06-14 Sloan-Kettering Institute For Cancer Research 2-fluoro-arabinofuranosyl purine nucleosides
US4965374A (en) * 1987-08-28 1990-10-23 Eli Lilly And Company Process for and intermediates of 2',2'-difluoronucleosides
US5223608A (en) * 1987-08-28 1993-06-29 Eli Lilly And Company Process for and intermediates of 2',2'-difluoronucleosides
EP0339161A1 (en) * 1988-04-01 1989-11-02 Merrell Dow Pharmaceuticals Inc. Novel fluorophosphonate nucleotide derivatives
JPH0232093A (ja) * 1988-06-08 1990-02-01 Merrell Dow Pharmaceut Inc 抗レトロウィルスジフルオロ化ヌクレオシド類
HU906976D0 (en) * 1989-11-13 1991-05-28 Bristol Myers Squibb Co Process for producing 2', 3'-didesoxy-2'-fluoarabinonucleoside analogues
US5175267A (en) * 1990-03-02 1992-12-29 University Of Georgia Research Foundation, Inc. Stereoselective glycosylation of hetercyclic bases
US5426183A (en) * 1992-06-22 1995-06-20 Eli Lilly And Company Catalytic stereoselective glycosylation process for preparing 2'-deoxy-2',2'-difluoronucleosides and 2'-deoxy-2'-fluoronucleosides
UA41261C2 (uk) * 1992-06-22 2001-09-17 Елі Ліллі Енд Компані Спосіб одержання збагачених бета-аномером нуклеозидів
US5371210A (en) * 1992-06-22 1994-12-06 Eli Lilly And Company Stereoselective fusion glycosylation process for preparing 2'-deoxy-2',2'-difluoronucleosides and 2'-deoxy-2'-fluoronucleosides
US5401838A (en) * 1992-06-22 1995-03-28 Eli Lilly And Company Stereoselective fusion glycosylation process for preparing 2'-deoxy-2',2'-difluoronucleosides and 2'-deoxy-2'-fluoronucleosides

Also Published As

Publication number Publication date
ATE210142T1 (de) 2001-12-15
NO972214D0 (no) 1997-05-14
SK283160B6 (sk) 2003-03-04
CZ292013B6 (cs) 2003-07-16
AR001045A1 (es) 1997-09-24
ZA959321B (en) 1997-05-05
BR9509904A (pt) 1997-10-14
CN1165519A (zh) 1997-11-19
PL182052B1 (pl) 2001-10-31
RU2161622C2 (ru) 2001-01-10
YU70995A (sh) 1998-09-18
SI0712860T1 (en) 2002-04-30
PE50196A1 (es) 1996-11-30
AU4139396A (en) 1996-06-17
EP0712860A3 (en) 1996-09-25
HUT77926A (hu) 1998-11-30
AU702588B2 (en) 1999-02-25
PT712860E (pt) 2002-05-31
IL115854A0 (en) 1996-01-31
MX9703548A (es) 1997-08-30
EP0712860B1 (en) 2001-12-05
CZ148197A3 (en) 1997-08-13
CA2205350A1 (en) 1996-05-30
EP0712860A2 (en) 1996-05-22
MY115183A (en) 2003-04-30
YU49446B (sh) 2006-03-03
CO4600741A1 (es) 1998-05-08
DE69524365D1 (de) 2002-01-17
US5606048A (en) 1997-02-25
RO118296B1 (ro) 2003-04-30
NZ296712A (en) 1999-01-28
BG62737B1 (bg) 2000-06-30
CN1044119C (zh) 1999-07-14
KR970707143A (ko) 1997-12-01
IL115854A (en) 2000-07-16
SK48597A3 (en) 1997-11-05
CA2205350C (en) 2007-09-04
BG101485A (en) 1998-03-31
KR100424990B1 (ko) 2004-05-20
DE69524365T2 (de) 2002-08-14
WO1996016072A1 (en) 1996-05-30
TW377356B (en) 1999-12-21
HU219019B (hu) 2001-01-29
JPH10509170A (ja) 1998-09-08
UA53614C2 (uk) 2003-02-17
NO972214L (no) 1997-05-14
DK0712860T3 (da) 2002-03-04
ES2164745T3 (es) 2002-03-01
PL320634A1 (en) 1997-10-13

Similar Documents

Publication Publication Date Title
NO308305B1 (no) FremgangsmÕte for rensing og isolering av et &lt;beta&gt;- anomeranriket nukleosid
NO993676D0 (no) Fremgangsmåte for fremstilling og rensing av et N-alkylert aspartamderivat
NO921485L (no) Fremgangsmaate og anlegg for avhendelse av borkaks
DK108997A (da) Fremstilling og krystalformer af 2-methylthien-benzodiazepin
NO951725L (no) Fremgangsmåte for fremstilling og/eller rensing av clavulansyre
NO940622D0 (no) Rensing fremgangsmåte og apparat
NO925001D0 (no) Fremgangsmaate og innretning til pyrolytisk spalting av hydrokarboner
NO20000695D0 (no) Fiberstruktur og fremgangsmÕte for fremstilling derav
FI954047A (fi) Ihmisen interleukiini-10:n puhdistaminen
NO961959L (no) Rensing av hemoglobin
NO982716L (no) FremgangsmÕte og blandinger for syntese av dioksalan-nukleotider med &lt;beta&gt;-konfigurasjon
NO932915L (no) Mikroporöst krystallinsk silikoaluminofosfat og fremgangsmåte for fremstilling av dette
NO972477D0 (no) Meso-mono-jod substituerte tetramakrocykliske forbindelser og fremgangsmåter for fremstilling og anvendelse
NO20005048L (no) Fremgangsmåte og rensing av diboran
NO950814D0 (no) Fremgangsmåte for fremstilling og rensing av joderte kontrastmidler
NO943248D0 (no) Rensing av naturgass
NO960255L (no) Fremgangsmåte for ekspresjon og rensing av P2 protein fra haemophilus influenzae type B
NO952261D0 (no) Antacidiumforbindelser og fremgangsmåte for fremstilling derav
DK54590A (da) Fremgangsmaade til modifikation og reduktion af kulaske
AU7701398A (en) Large-scale isolation and purification of hif
FI942834A0 (fi) Menetelmä kaasujen puhdistamiseksi
NO993714D0 (no) Transformator/reaktor og fremgangsmåte for fremstilling av en transformator/reaktor
DK4791D0 (da) Fremgangsmaade og anlaeg til overfoersel af affald
TR23973A (tr) Feniltio uereler fenilnoti uereler ve fenil karbodi- imidler bunlarin elde edilmeleri
NO982734D0 (no) FremgangsmÕte for rensing av rekombinant humaninterleukin-8

Legal Events

Date Code Title Description
MM1K Lapsed by not paying the annual fees